NCT07321717

Brief Summary

Circumcision is one of the most frequently performed surgical procedures in childhood and is associated with significant postoperative pain. This randomized controlled trial (RCT) aims to compare the analgesic effectiveness of sacral erector spinae plane block (sacral ESPB) and penile nerve block (PNB) in children undergoing circumcision surgery. The primary outcome is postoperative pain, assessed using the Face, Legs, Activity, Cry, and Consolability (FLACC) scale at predefined time intervals within the first 24 hours after surgery. Secondary outcomes include intraoperative analgesic consumption, time to first postoperative analgesic requirement, perioperative hemodynamic changes. The results of this study are expected to provide evidence for selecting the optimal regional analgesic technique for pediatric circumcision surgery.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jan 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 23, 2025

Completed
9 days until next milestone

Study Start

First participant enrolled

January 1, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 7, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 20, 2026

Completed
21 days until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2026

Completed
Last Updated

January 7, 2026

Status Verified

December 1, 2025

Enrollment Period

3 months

First QC Date

December 23, 2025

Last Update Submit

December 23, 2025

Conditions

Keywords

pediatric regional anesthesiasacral ESP

Outcome Measures

Primary Outcomes (1)

  • Postoperative Pain Scores within 24 Hours

    Postoperative pain will be assessed using the FLACC scale (Face, Legs, Activity, Cry, Consolability) at multiple time points (0, 1, 2, 4, 8, 12, 16, and 24 hours postoperatively). Scores range from 0-10, where higher scores indicate more severe pain and lower scores indicate less pain. The primary outcome is the comparison of pain levels between the Sacral Erector Spinae Plane Block (SESPB) group and the Penile Nerve Block (PNB) group during the first 24 hours after surgery.

    0-24 hours after circumcision surgery

Secondary Outcomes (3)

  • Total Analgesic Consumption in 24 Hours

    0-24 hours postoperatively

  • Intraoperative Analgesic Consumption

    During surgery

  • Time to First Analgesic Requirement

    0-24 hours postoperatively

Study Arms (2)

Penile Nerve Block (PNB) group

ACTIVE COMPARATOR

Participants in this group will receive the standard penile nerve block prior to surgery. The block is performed by subcutaneous infiltration of 0.5 ml/kg of 0.25% bupivacaine around the ventral penoscrotal junction and base of the penis. This is the standard clinical practice group used for comparison.

Procedure: Penile Nerve Block (PNB)

Sacral Erector Spinae Plane Block (SESPB) group

EXPERIMENTAL

Participants in this group will receive a sacral ESPB before circumcision surgery. The block is performed with 0.5 ml/kg of 0.25% bupivacaine under ultrasound guidance using an in-plane, craniocaudal approach while the child is in the prone position. This is the investigational intervention being studied for analgesic effectiveness and safety.

Procedure: Sacral Erector Spinae Plane Block

Interventions

Participants will receive a sacral ESPB prior to circumcision surgery. 0.5 ml/kg of 0.25% bupivacaine is injected under ultrasound guidance using an in-plane, craniocaudal approach while the child is in the prone position. This is the investigational procedure being studied for analgesic effectiveness and safety.

Sacral Erector Spinae Plane Block (SESPB) group

Participants will receive the standard penile nerve block prior to surgery. 0.5 ml/kg of 0.25% bupivacaine is infiltrated subcutaneously around the ventral penoscrotal junction and base of the penis. This serves as the standard comparator.

Penile Nerve Block (PNB) group

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Age between 1 and 12 years
  • Scheduled for circumcision surgery
  • Classified as American Society of Anesthesiologists (ASA) physical status I-II
  • Written informed consent obtained from both the participant (when appropriate) and their parents or legal guardians

You may not qualify if:

  • Age under 1 year or over 12 years
  • Undergoing circumcision combined with other surgical procedures
  • Presence of neurological deficits
  • History of bleeding diathesis
  • Allergy to local anesthetic (LA) drugs
  • Redness or infection at the injection site
  • Presence of congenital sacral anomalies
  • Mental retardation
  • Psychiatric disorders or kidney disease
  • Refusal to participate in the study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

Bakırköy, Istanbul, 34153, Turkey (Türkiye)

Location

Study Officials

  • Munevver Kayhan

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    PRINCIPAL INVESTIGATOR
  • Pinar Kendigelen

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    STUDY CHAIR
  • Ayse Cigdem Tutuncu, Professor Doctor

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    STUDY CHAIR
  • Ali Ekber Hakalmaz, Lecturer Doctor

    Istanbul University-Cerrahpasa, Cerrahpasa Medicine of Faculty

    STUDY CHAIR

Central Study Contacts

Munevver Kayhan, Lecturer Doctor

CONTACT

Pinar Kendigelen, Professor Doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
This study is double-blind to compare the analgesic effectiveness and safety of Penile Nerve Block (PNB) and Sacral Erector Spinae Plane Block (sacral ESPB) in pediatric circumcision. Participants (children) and outcome assessors are unaware of group assignment to minimize bias. Postoperative pain and outcomes are measured using the FLACC scale (Face, Legs, Activity, Cry, Consolability), where higher scores indicate more severe pain and lower scores less pain. Only the anesthesiologists performing the blocks know the assigned intervention for safety and correct technique; they do not collect postoperative data. Blinding ensures objective assessment of pain, analgesic consumption, hemodynamic changes, and complications during the perioperative and postoperative period.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Participants will be randomly assigned to one of two independent groups: the Penile Nerve Block (PNB) group or the Sacral Erector Spinae Plane Block (sacral ESPB) group. Each participant will receive only the assigned intervention and will be followed throughout the perioperative and postoperative period. The parallel design allows comparison of analgesic effectiveness, safety, and postoperative outcomes between the two independent groups
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

December 23, 2025

First Posted

January 7, 2026

Study Start

January 1, 2026

Primary Completion

March 20, 2026

Study Completion

April 10, 2026

Last Updated

January 7, 2026

Record last verified: 2025-12

Data Sharing

IPD Sharing
Will not share

Locations